close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ALPMY

Recent news which mentions ALPMY

< Previous 1 2 Next >
Super Bowl Commercials 2023: The Complete List Of Super Bowl LVII Ads And The Companies Behind Them
Tickers ALPMY AMZN BKNG BUD
Tags Kevin Hart Benzinga FOX
From Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Tickers ALPMF ALPMY HZNP SELB
Tags Health Care Briefs Analyst Ratings
From Benzinga
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
Tickers ALPMF ALPMY GSK NVS
Tags ALPMY ALPMF Benzinga
From Benzinga
What Is Going on With Taysha Gene (TSHA) Stock Today?
Tickers ALPMY TSHA
Tags ALPMY Market News Today's Market
From InvestorPlace
Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs
Tickers ALPMF ALPMY TSHA
Tags ALPMY ALPMF Benzinga
From Benzinga
Astellas' Menopause Drug Under FDA Review
Tickers ALPMF ALPMY
Tags Market News ALPMY News
From Benzinga
Seagen Shares Jump On Positive Data From Urothelial Cancer Trial
Tickers ALPMF ALPMY MRK SGEN
Tags General Large Cap Market News
From Benzinga
7 Best Biotech Stocks to Buy in July 2022
Tickers AAPL ALPMY AMGN AZN
Tags Stocks to Buy DNA IONS
From InvestorPlace
Sutro Biopharma Stock Surges On Cancer Treatment Pact
Tickers ALPMF ALPMY STRO
Tags Movers Briefs Trading Ideas
From Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Tickers ALPMF ALPMY AXSM AZN
Tags IPSEY MITO ALPMY
From Benzinga
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
Tickers ALPMF ALPMY
Tags FDA Health Care Biotech
From Benzinga
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
Tickers ALPMF ALPMY TWST
Tags Biotech News Contracts
From Benzinga
Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer
Tickers ALPMF ALPMY SGEN
Tags Market News European Medicines Agency ALPMY
From Benzinga
Astellas' Menopause Drug Suffers Setback After Failed Asian Trial
Tickers ALPMF ALPMY
Tags General Benzinga ALPMF
From Benzinga
Got $1,000? Here's a Dirt-Cheap Big Pharma Stock to Buy
Tickers ALPMY BMY BNTX JNJ
Tags Recent Press Releases BNTX ALPMY
From Motley Fool
Astellas Touts Safety Data For Phase 3 Menopause Drug, Sets Up US Filing
Tickers ALPMF ALPMY
Tags Biotech Health Care Briefs
From Benzinga
Astellas Pharma - Seagen's Enfortumab Shows 36% Pathologic Complete Response In Bladder Cancer Patients
Tickers ALPMF ALPMY SGEN
Tags News ALPMY Market News
From Benzinga
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
Tickers ADAP AGEN ALPMY GSK
Tags XBI AGEN ALPMY
From Motley Fool
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Tickers ALPMF ALPMY NVS RHHBF
Tags Biotech NVS RHHBF
From Benzinga
Astellas Pharma's Bladder Cancer Treatment Scores Approval In Japan
Tickers ALPMF ALPMY
Tags FDA Health Care Biotech
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Tickers ABT ACAD ADGI ALPMY
Tags ACAD MTEM MDT
From Benzinga
Astellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical Hold
Tickers ALPMF ALPMY
Tags Health Care Briefs Neuromuscular Disorder
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Tickers ACIU ADGI ALKS ALPMY
Tags BNR FDA REGN
From Benzinga
See Why Astellas Stopped Dosing In Neuromuscular Disease Gene Therapy Trial
Tickers ALM ALPMF ALPMY
Tags Biotech FDA gene therapy
From Benzinga
After FDA Rejection, EMA Approves FibroGen-Astellas' Roxadustat
Tickers AKBA ALPMF ALPMY AZN
Tags FGEN News Long Ideas
From Benzinga
Here's What Recent News From the FDA Means for AstraZeneca
Tickers ALPMY AZN FGEN
Tags AZN Market News ALPMY
From Motley Fool
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Tickers ABVC ACAD ACET ADMA
Tags URGN GOVX CTMX
From Benzinga
FibroGen Shares Are Trading Lower As FDA Shoots Down Roxadustat Application, Asks For Additional Trial
Tickers ALPMF ALPMY AZN FGEN
Tags News FGEN Market News
From Benzinga
Why Investors Should Like BioNTech's Latest Deal With Gilead
Tickers ALPMY BNTX GILD PFE
Tags BNTX PFE ALPMY
From Motley Fool
The IPO Recap – Party Is Everything But Over
Tickers ABSI ALPMY BASE CNM
Tags CTKB ABSI CNM
From Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today